News
Summit Therapeutics highlights China approval of Akeso's ivonescimab for NSCLC, with enrollment ongoing for Phase 3 HARMONi-7 ...
Summit Therapeutics (SMMT) stock plunges 35% a day after the FDA approval of partner Akeso's (AKESF) cancer drug, ...
We recently compiled a list of the 13 Best Aggressive Growth Stocks to Buy Now. In this article, we are going to take a look ...
Ping Wei powder is a type of traditional Chinese medicine used to treat digestive system diseases. Its growth in popularity ...
Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...
MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today provides an update on its commercial and ...
Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution. Check out why SMMT stock is a hold.
Now, however, a study by HE Zhuohao’s team from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences ... the findings identify the fuzzy coat as a potential therapeutic ...
What Is Alpha-Lipoic Acid? Alpha-lipoic acid (ALA) is an antioxidant that your body makes. You also get it from foods such as broccoli, carrots, potatoes, and red meat. ALA is produced in small ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
MANILA, Philippines — Seeking accountability for the Chinese-led dredging in the waters off Cagayan province should not stop just because operations have ceased, ACT Teachers party-list leaders ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results